Germany In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

The report covers IVD Market in Germany Forecast and it is segmented by Test Type (Clinical Chemistry, Molecular Diagnostics, Immuno Diagnostics, Hematology, and Other Test Types), Product (Instruments, Reagents, and Other Products), Usability (Disposable IVD Devices and Reusable IVD Devices), Application (Infectious Disease, Diabetes, Cancer/Oncology, Cardiology, Autoimmune Disease, Nephrology, and Other Applications) and End User (Diagnostic Laboratories, Hospitals and Clinics, and Other End Users). The report offers the value (in USD million) for the above segments.

Germany In-Vitro Diagnostics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)

Germany In-Vitro Diagnostics (IVD) Industry Overview

The Germany in-vitro diagnostics market is fragmented with several market players. The market has rapidly evolved over the last few years. Industry observed significant changes in adopting market strategies such as product developments, mergers, and acquisitions in recent years. Thus, the German In-Vitro Diagnostics market has become a very competitive industry. Some of the players in the market include Abbott Laboratories, Becton, Dickinson and Company, Bio-Rad Laboratories Inc., bioMerieux SA, Danaher Corporation, Epigenomics Inc., F. Hoffmann-La Roche Ltd, Johnson & Johnson, Qiagen N.V., and Siemens Healthcare GmbH.

Germany In-Vitro Diagnostics (IVD) Market Leaders

  1. Qiagen N.V.

  2. Siemens Healthcare GmbH

  3. Epigenomics Inc.

  4. Abbott Laboratories

  5. F. Hoffmann-La Roche Ltd

  6. *Disclaimer: Major Players sorted in no particular order
german.png

Germany In-Vitro Diagnostics Market Report Snapshots

80% of our clients seek made-to-order reports. How do you want us to tailor yours?